Business

Study Flags Possible Bone and Gout Risks With GLP-1s

Introduction A new observational study suggests people taking GLP-1 weight loss and diabetes drugs may face slightly higher rates of osteoporosis and gout over time. The research, led by Dr....

Apple Launches iPhone 17e Starting at $599

Introduction Apple has expanded its iPhone lineup with the iPhone 17e, a lower-priced model aimed at buyers who want...

Study Links PFAS Exposure to Faster Aging in Men 50–65

Introduction A new study suggests that exposure to PFAS, often called “forever chemicals,” may be associated with faster biological...

US Moves to Cut Swiss Bank MBaer From Dollar Access

Introduction The U.S. Treasury has taken a rare and highly consequential step against MBaer Merchant Bank AG, proposing to...

Kalshi Sanctions MrBeast Editor in Trading Probe

Introduction Kalshi said it fined and suspended an employee of the YouTuber known as MrBeast for insider trading, a...
spot_img

Trump Strengthens U.S.-UAE Ties Amid AI Push and Trade Deals

President Donald Trump made a visit to the United Arab Emirates (UAE) on Thursday, where he pledged to deepen the U.S.'s relationship with the...

New Car Prices Hold Steady Despite Tariffs, Inventory Shields Buyers

The April Consumer Price Index (CPI) report revealed that new car prices were flat, surprising many who expected President Trump’s auto sector tariffs to...

UnitedHealth Group Faces Turmoil: A Timeline of Challenges

CEO Andrew Witty Steps Down Amid Challenges UnitedHealth Group has seen a tumultuous year marked by several high-profile incidents, leading to the sudden departure of...

Panasonic Cuts 10,000 Jobs, Focuses on EV Battery Profits

Panasonic Holdings (6752.T) said on Friday it will cut 10,000 staff and expects to book restructuring costs of 130 billion yen ($896.06 million) this...

Block Shares Drop 22% on Lower 2025 Profit Forecast

Shares Plunge Amid Concerns Over Cash App and Competition Block’s (XYZ.N) stock plunged 22% on Friday, marking the largest intraday decline in five years. The...

Novo Nordisk Wins Legal Battle Against Compounding Pharmacies

In a major legal victory for Novo Nordisk, a Texas federal judge ruled to restrict compounding pharmacies from producing and selling cheaper, unapproved versions...